Home > Income Statement > DIVIS LABORATORIES

DIVIS LABORATORIES
Revenue

    Back to Income Statement
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹7,845 Cr₹7,767 Cr₹8,960 Cr₹6,969 Cr₹5,394 Cr

What is the latest Revenue of DIVIS LABORATORIES ?

The latest Revenue ratio of DIVIS LABORATORIES is ₹7,845 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹7,845 Cr
Mar2023₹7,767 Cr
Mar2022₹8,960 Cr
Mar2021₹6,969 Cr
Mar2020₹5,394 Cr

How is Revenue of DIVIS LABORATORIES Trending?

Years Revenue % Change
Mar2024 ₹7,845 Cr
1.00
Mar2023 ₹7,767 Cr
-13.31
Mar2022 ₹8,960 Cr
28.56
Mar2021 ₹6,969 Cr
29.20
Mar2020 ₹5,394 Cr -

Compare Revenue of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹158,673.4 Cr 2.4% 2.2% 59.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,617.0 Cr -2.1% -9% 9.1% Stock Analytics
CIPLA ₹119,511.0 Cr 1.4% 2% 0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹104,734.0 Cr -0.9% -2.8% 16.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,705.1 Cr -2.1% -9.2% -8.7% Stock Analytics
MANKIND PHARMA ₹96,821.9 Cr -2.1% -10.9% 7.9% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

2.4%

2.2%

59.7%

SENSEX

-0.4%

-1.4%

5.4%


You may also like the below Video Courses